Alaunos Therapeutics, Inc. (TCRT) stock
TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.72+0.06 (+3.61%)
Close on Nov 18, 2026Market cap $4.37MP/E –Yield –
Alaunos Therapeutics cash
Cash and short-term investments held at the end of each period.
Alaunos Therapeutics's cash was $124.00K at Jun 30, 2026. For fiscal 2025 it was $1.39M, up 26.9% from the year before. Over ten years it grew -37.0% a year on average. The highest annual figure on record is $140.72M in fiscal 2015.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.39M | +26.9% |
| FY2024 | Dec 31, 2024 | $1.09M | -82.0% |
| FY2023 | Dec 31, 2023 | $6.06M | -88.6% |
| FY2022 | Dec 31, 2022 | $53.00M | -30.3% |
| FY2021 | Dec 31, 2021 | $76.05M | -33.9% |
| FY2020 | Dec 31, 2020 | $115.07M | +44.3% |
| FY2019 | Dec 31, 2019 | $79.74M | +29.2% |
| FY2018 | Dec 31, 2018 | $61.73M | -13.5% |
| FY2017 | Dec 31, 2017 | $71.33M | -12.4% |
| FY2016 | Dec 31, 2016 | $81.44M | -42.1% |
| FY2015 | Dec 31, 2015 | $140.72M | +228.8% |
| FY2014 | Dec 31, 2014 | $42.80M | -37.2% |
| FY2013 | Dec 31, 2013 | $68.20M | -7.0% |
| FY2012 | Dec 31, 2012 | $73.31M | -30.0% |
| FY2011 | Dec 31, 2011 | $104.71M | +73.4% |
| FY2010 | Dec 31, 2010 | $60.39M | +23.7% |
| FY2009 | Dec 31, 2009 | $48.84M | +329.2% |
| FY2008 | Dec 31, 2008 | $11.38M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $124.00K | -95.7% |
| Q1 FY2026 | Mar 31, 2026 | $354.00K | +11.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.39M | +26.9% |
| Q3 FY2025 | Sep 30, 2025 | $1.94M | +15.2% |
| Q2 FY2025 | Jun 30, 2025 | $2.88M | +16.8% |
| Q1 FY2025 | Mar 31, 2025 | $319.00K | -92.3% |
| Q4 FY2024 | Dec 31, 2024 | $1.09M | -82.0% |
| Q3 FY2024 | Sep 30, 2024 | $1.68M | -85.9% |
| Q2 FY2024 | Jun 30, 2024 | $2.46M | -86.5% |
| Q1 FY2024 | Mar 31, 2024 | $4.15M | -88.9% |
| Q4 FY2023 | Dec 31, 2023 | $6.06M | -88.6% |
| Q3 FY2023 | Sep 30, 2023 | $11.94M | -76.9% |
| Q2 FY2023 | Jun 30, 2023 | $18.32M | -69.5% |
| Q1 FY2023 | Mar 31, 2023 | $37.43M | -45.2% |
| Q4 FY2022 | Dec 31, 2022 | $53.00M | -30.3% |
| Q3 FY2022 | Sep 30, 2022 | $51.75M | -43.6% |
| Q2 FY2022 | Jun 30, 2022 | $60.01M | -21.8% |
| Q1 FY2022 | Mar 31, 2022 | $68.26M | -40.7% |
| Q4 FY2021 | Dec 31, 2021 | $76.05M | -43.9% |
| Q3 FY2021 | Sep 30, 2021 | $91.73M | -40.3% |
| Q1 FY2021 | Jun 30, 2021 | $76.75M | -55.1% |
| Q4 FY2020 | Dec 31, 2020 | $115.07M | +44.3% |
| Q3 FY2020 | Sep 30, 2020 | $135.47M | +53.2% |
| Q2 FY2020 | Jun 30, 2020 | $153.52M | +252.4% |
| Q1 FY2020 | Mar 31, 2020 | $171.00M | +232.1% |
| Q4 FY2019 | Dec 31, 2019 | $79.74M | +29.2% |
| Q3 FY2019 | Sep 30, 2019 | $88.42M | +175.3% |
| Q2 FY2019 | Jun 30, 2019 | $43.56M | +6.8% |
| Q1 FY2019 | Mar 31, 2019 | $51.49M | +0.7% |
| Q4 FY2018 | Dec 31, 2018 | $61.73M | -13.5% |
| Q3 FY2018 | Sep 30, 2018 | $32.12M | -61.9% |
| Q2 FY2018 | Jun 30, 2018 | $40.79M | -58.0% |
| Q1 FY2018 | Mar 31, 2018 | $51.11M | -23.1% |
| Q4 FY2017 | Dec 31, 2017 | $71.33M | -12.4% |
| Q3 FY2017 | Sep 30, 2017 | $84.41M | -10.9% |
| Q2 FY2017 | Jun 30, 2017 | $97.19M | -10.8% |
| Q1 FY2017 | Mar 31, 2017 | $66.45M | – |
| Q4 FY2016 | Dec 31, 2016 | $81.44M | – |
| Q3 FY2016 | Sep 30, 2016 | $94.68M | – |
| Q2 FY2016 | Jun 30, 2016 | $109.00M | – |
See a number that looks wrong?